WASHINGTON (Reuters) - U.S. drug regulators gave the nod on Tuesday to Protalix Biotherapeutics Inc and Pfizer Inc's experimental biotech drug for a form of the rare genetic disease Gaucher. full story ![]()
Filed under: Investing Pfizer's Palbociclib (PD-0332991) Receives Food And Drug Administration Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has...
dailyfinance.com (1 month and 7 days ago)

The FDA approved Diclegis, a morning sickness drug, which was pulled from the market 30 years ago, now has the highest FDA safety rating for a pregnancy drug.
abcnews.com (1 month and 7 days ago)
The FDA approved a new drug that will be marketed by GlaxoSmithKline to treat chronic obstructive pulmonary disease, or COPD.
wsj.com (7 days ago)
The FDA strengthened warnings on Pfizer's antibiotic Zithromax, saying there is a small chance the product may trigger a potentially fatal, irregular heart rhythm.
wsj.com (2 months and 7 days ago)
Diclegis was previously known as Bendectin, a drug pulled from market in 1983 amid lawsuits claiming birth defects; FDA says studies confirmed drug's safety
cbsnews.com (1 month and 7 days ago)
The FDA has approved a new drug for multiple sclerosis targeted for adult patients with hard-to-control symptoms. Charlie Rose reports.
cbsnews.com (1 month and 20 days ago)
(Reuters) - The U.S. Food and Drug Administration approved a Merck & Co cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday.
reuters.com (14 days ago)
FDA approves new targeted breast cancer drug by Mathew Perrone The Associated Press Published Feb 22, 2013 08:59AM MDT WASHINGTON • The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones. The drug Kadcyla (kad-SY’-luh) from Roche combines the established drug Herceptin with a powerful...
sltrib.com (2 months and 25 days ago)
The FDA approved a powerful new type of drug that will be marketed by Roche to treat breast cancer.
wsj.com (2 months and 25 days ago)
Pfizer updated the drug's label.
usatoday.com (2 months and 7 days ago)
Brown Bird Cancels Upcoming Tour Dates
Matching Colors With Songs...It's Science!
E. Nina Rothe: The Man Inside by Karim...
Carol Dombrow: Divide and Conquer: How...
Another Family Rescued From Everglades
Lois Alter Mark: A Grandfather's Gift...
Trevor Gair: Death and Re-birth in...
Vitamin Daily: The Girl's Guide to...
British holidaymaker drowns in front of...
Day spa for kids in The Maldives
Naturally, it's easy to relax on the NSW...
Fine powder for making tracks at Thredbo
Harlequin ladybird can be a pest in...
Asteroid nine times larger than the QE2...
Meteoroid impact triggers bright flash...
Alaska volcano shoots ash 15,000 feet...
LHC Creates Tiny Drops of Big Bang...
The Week In Numbers: Fire In Space, The...
Moon Rocked By Biggest Meteorite Explosion
The World's Fastest Wi-Fi Puts Your...
New Xbox more than a game console for...
Google's wearable Glass gadget: cool or...
New Xbox more than a game console for...
Google's wearable Glass gadget: cool or...
Polota-Nau set to miss Lions tour
Bradford City 3 Northampton Town 0:...
RFU council agrees changes to modernise...
Will MLS have the first openly gay athlete?
Houston Astros (11-31) at Pittsburgh...
Kings make late comeback to take Game 2
More Bad News For Best-Selling Author In...
'Stuck in the Middle' offers a singular...
Bookshelf: Books on New York History and...
Queenan: Stop the Run of Revisionist...
Cecil Castellucci: What You Miss Out On...
Max Allan Collins: WATCH: 10 Best Spy...
When I got to the marathon starting line earlier this month, I knew that my 18 weeks of training...
One doctor is going to the front lines in the battle against a new strain of bacterial meningitis...
Q: What symptoms should parents watch for if they are worried a young child may have autism? Is...